Funda Uğur Kantar

Dr. Funda Uğur Kantar

orcid

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2011 in Turkish Journal of Gastroenterology
Verified
Journal Article
Closed access
FKFunda Uğur Kantar
Funda Uğur Kantar
MAMesut Akarsu
Mesut Akarsu
KAKoray Atilla
Koray Atilla
OSOzgul Sagol
Ozgul Sagol
MSMujde Soyturk
Mujde Soyturk
HAHale Akpinar
Hale Akpinar
Ectopic pancreas, diarrhea, duodenum

1 November 2014 in The American Journal of Emergency Medicine
Verified
Journal Article
Closed access
OLOnder Limon
Onder Limon
FKFunda Uğur Kantar
Funda Uğur Kantar
EŞErkan Şahin
Erkan Şahin
MAMurat Arslan
Murat Arslan
AUAslı Aydınoglu Ugurhan
Aslı Aydınoglu Ugurhan

28 October 2022 in African Health Sciences
Verified
Journal Article
Open access
PDF file
FKFunda Uğur Kantar
Funda Uğur Kantar
SKSelda Kahraman
Selda Kahraman
GEGulfem Ece
Gulfem Ece
SCSeckin Cagırgan
Seckin Cagırgan
Objectives: Hepatitis B infection is an important problem in immune suppressed patients. Anti HbcAb is an important marker that shows past exposure to virus. In this study, we retrospectively searched HBV serology among the patients who had Bone Marrow Transplantation (BMT) or chemotherapies (CT) at Medicalpark Izmir Hospital Bone Marrow Transplantation Unit; changes in viral parameters throughout therapy; and tried to find the efficiency of antiviral prophylaxis . Methods: We retrospectively evaluated the viral parameters; HbsAg, Anti HbsAb, Anti Hbc IgG, HbeAg, Anti Hbe Ab, HBV DNA, HCV RNA which were carried out before BMT and CT. We grouped the patients as latent HBV infection and inactive carriers .Started antiviral treatment as prophylaxis, monitored the changes in serological parameters and defined HBV related situations. Results: A total of 584 patients were evaluated retrospectively. Twenty patients were having latent HBV infection. Ten patients were inactive carriers of HBV. In post-transplant period, the patients were screened for 11 months (1-38 months). None of the patients experienced HBV activation during follow period. Conclusion: The best approach in HbcAb positive patients with planned immunosuppressive treatment is the use of anti-viral agents before immune suppression and close monitoring of the patients HBV-related markers . Keywords: Hepatitis B; Hematologic Malignancy; stem cell transplantation.

6 July 2014 in Turkish Journal of Gastroenterology
Verified
Journal Article
Closed access
OTOmer Topalak
Omer Topalak
FKFunda Uğur Kantar
Funda Uğur Kantar
CUCagnur Ulukus
Cagnur Ulukus
AKAli Kupelioglu
Ali Kupelioglu
Background/Aims: Insulin-like growth factor-1 receptor (IGF-1R) plays critical roles in cell proliferation, differentiation, apoptosis, and transformation. Suppression of IGF-1R by means of antisense methods and specific antibodies causes cell apoptosis and growth inhibition of cancer cells. The present study aims to investigate whether there is a difference between normal and cancerous tissue with respect to IGF-1R expression and to assess the relationship between IGF-1R expression and tumor stage, degree of differentiation, and lymph node metastasis by examining IGF-1R expression in cancerous and normal tissues of gastric adenocarcinoma cases of different stages. Materials and Methods: By using immunohistochemical methods, IGF-1Rb (H-60) (1/100, Santa Cruz Biotechnology, SC-9038, Texas,USA) expression was investigated in paraffin-embedded blocks obtained from total/partial gastrectomy material pertaining to 47 gastric adenocarcinoma cases. IGF-1R expression was evaluated semi-quantitatively in terms of intensity and distribution in both normal and cancerous tissues. Results: Insulin-like growth factor-1 receptor expression mean score was 5.38 and 8.40 for cancerous and for normal gastric tissues, respectively. IGF-1R expression decreased significantly in cancerous tissues compared normal tissue (p:0.001). When all cases with and without lymph node metastasis were analyzed, IGF-1R expression was observed to decrease for cases with lymph node metastasis compared to those without lymph node metastasis (p:0.035). Conclusion: Insulin-like growth factor-1 receptor expression in gastric cancer tissue has proven to be considerably lower than IGF-1R expression in normal gastric mucosa. Metastatic progression reduces IGF-1R expression gradually in cancer tissue.

8 August 2025 in Ahi Evran Medical Journal
Verified
Journal Article
Open access
FKFunda Uğur Kantar
Funda Uğur Kantar
Purpose: Foreign body (FB) ingestion and its impact on gastrointestinal system is one of the most common health problems and emergency situations in gastrointestinal practice. Management of FB may be a great challenge for the endoscopist. We aimed to evaluate the FB in gastrointestinal system and their management. Materials and Methods: This retrospective study included adult patients with the complaint of FB in upper digestive system. We evaluated the demographic findings of the patients, characteristic of the FB, endoscopic treatment methods and complications from medical records. Results: Total of 85 patients with the complaint of FB ingestion underwent gastroscopy. The mean age of the patients was 46.69 (19-87 years). The ratio of males/females was 66.7% / 33.3%. In 36% of patients, the ingestion of FB was intentionally, whereas 64 % ingested FB accidentally. In cases who ingested FB intentionally, the majority of FB were metallic objects such as lighter, razor blade, battery. Esophageal perforation (1.3%), micro perforation (1.3%), mucosal self-limited bleeding (1.3%), ulcers and superficial lacerations (4%) in esophagus were most important complications which were observed in 6 patients (8%). Conclusion: Our study showed a great variability of FB ingested either intentional or accidentally. The endoscopic approach for retrieval of these subjects is both effective and safe, without significant complications.

12 June 2025 in İzmir Tıp Fakültesi Dergisi
Verified
Journal Article
Open access
PDF file
FKFunda Uğur Kantar
Funda Uğur Kantar
GHGozde Dervis Hakim
Gozde Dervis Hakim
MAMesut Akarsu
Mesut Akarsu
TUTARKAN UNEK
TARKAN UNEK
MÖMücahit Özbilgin
Mücahit Özbilgin
İAİbrahim Astarcıoğlu
İbrahim Astarcıoğlu
Aim: Liver transplantation (LT) is the only definitive treatment for end-stage liver disease. Graft rejection is also an important complication of LT due to its high economic burden. In this descriptive study, we aimed to explore complications of liver transplantation, cost of graft rejection and identify factors associated with this complication. Methods: A total of 455 liver transplantations were performed between 1998 and 2016 in a University Hospital, in Turkey. Among these 455 patients, 43 patients with an episode of acute graft rejection which were documented histologically by using Banff Schema were selected for this retrospective study. The cost of hospitalization during graft rejection period were recorded as specific cost associated factors such as intensive care unit, dialysis, blood bank, laboratory, radiology, medications and medical equipment. Results: The mean cost of acute graft rejection was 12423,74 (315,00-61236,94) American Dollars. Most important components of the total cost were medications, laboratory and medical equipment. The cost of acute rejection was independent of United Network for Organ Share (UNOS), (p:0.928), Model for End-stage Liver Disease (MELD) (p:0.935) scores, type of donation (p:0.976), age (p:0.464) and gender (p:0.584) of the patient. Conclusion: The cost of acute graft rejection is independent of the patients’ characteristics. The importance of this study is that it is the first study of cost analysis among liver transplanted patients with an episode of acute rejection in Turkey which are very rare studies throughout the world Keywords: liver transplantation, rejection, cost analysis.